Press release -

Cavidi wins SWECARE Export Award 2012

Leading Swedish HIV diagnostic supplier Cavidi has been awarded the Swecare Export Award for 2012. Cavidi gets the award with the following motivation from Swecare:

Cavidi is a company that has shown significant development in exports in the last years. They have a novel HIV "RT" diagnostic technology discovered in Uppsala that is now being successfully commercialized in Africa, India, and South East Asia. 

Commenting on the award CEO John Reisky de Dubnic said. “We are proud to receive the Swecare Export Award as recognition of the progress we are making at Cavidi. The HIV diagnostics market is expected to be worth 4 billion USD by 2020 and we intend to be a leading player with our patented, robust, and reliable test methods.”

For more information about Swecare and the Swecare Export award please refer to http://www.swecare.com/activities/swecare-export-award

Topics

  • Medical research

Categories

  • viral load
  • swecare export award 2012
  • sweden
  • hiv
  • health care
  • cavidi
About Cavidi
Cavidi is a leading Swedish supplier of companion diagnostics for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can lead a normal productive life. Cavidi’s companion diagnostics reduce the cost of treatment and the improve the efficasy of HIV care. Cavidi is a Swedish biotech company with its head office in Uppsala and sales offices in South Africa, India and USA. www.cavidi.com 


Contacts

Andrew Oldfield

Press contact Corporate Communications +46(0)702798454